Cargando…

Taurine: a potential marker of apoptosis in gliomas

New cancer therapies are being developed that trigger tumour apoptosis and an in vivo method of apoptotic detection and early treatment response would be of great value. Magnetic resonance spectroscopy (MRS) can determine the tumour biochemical profile in vivo, and we have investigated whether a spe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Opstad, K S, Bell, B A, Griffiths, J R, Howe, F A
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2009
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653765/ https://www.ncbi.nlm.nih.gov/pubmed/19223899 http://dx.doi.org/10.1038/sj.bjc.6604933

Ejemplares similares

Prognostic molecular markers with no impact on decision-making: the paradox of gliomas based on a prospective study
por: Wager, M, et al.
Publicado: (2008)

Serum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of glioma
por: Lai, N-s, et al.
Publicado: (2015)

Plasminogen activator inhibitor-1 as a potential marker for the malignancy of colorectal cancer
por: Sakakibara, T, et al.
Publicado: (2005)

Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas
por: Martinho, O, et al.
Publicado: (2009)

Bicalutamide-induced hypoxia potentiates RUNX2-mediated Bcl-2 expression resulting in apoptosis resistance
por: Browne, G, et al.
Publicado: (2012)

GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma
por: Xue, Y, et al.
Publicado: (2014)

Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer
por: Landers, K A, et al.
Publicado: (2008)

Expression of neutrophil gelatinase-associated lipocalin in colorectal neoplastic progression: a marker of malignant potential?
por: McLean, M H, et al.
Publicado: (2013)

Hypoxia-associated markers in gastric carcinogenesis and HIF-2α in gastric and gastro-oesophageal cancer prognosis
por: Griffiths, E A, et al.
Publicado: (2008)

Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients
por: Ruiz, M I Galleges, et al.
Publicado: (2009)

Markers for the non-invasive diagnosis of mesothelioma: a systematic review
por: van der Bij, S, et al.
Publicado: (2011)

Gene expression profiles of gliomas in formalin-fixed paraffin-embedded material
por: Gravendeel, L A M, et al.
Publicado: (2012)

PROX1 is a predictor of survival for gliomas WHO grade II
por: Elsir, T, et al.
Publicado: (2011)

The role of versican isoforms V0/V1 in glioma migration mediated by transforming growth factor-β2
por: Arslan, F, et al.
Publicado: (2007)

Integrin α3 is overexpressed in glioma stem-like cells and promotes invasion
por: Nakada, M, et al.
Publicado: (2013)

DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer
por: Drouillard, A, et al.
Publicado: (2016)

Maspin is a marker for early recurrence in primary stage III and IV colorectal cancer
por: Snoeren, N, et al.
Publicado: (2013)

Inducing apoptosis of cancer cells using small-molecule plant compounds that bind to GRP78
por: Martin, S, et al.
Publicado: (2013)

Endosialin expression in soft tissue sarcoma as a potential marker of undifferentiated mesenchymal cells
por: Thway, Khin, et al.
Publicado: (2016)

Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer
por: Wallin, U, et al.
Publicado: (2011)

UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer
por: Unoki, M, et al.
Publicado: (2009)

Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer
por: Jubb, A M, et al.
Publicado: (2009)

Nuclear osteopontin-c is a prognostic breast cancer marker
por: Zduniak, K, et al.
Publicado: (2015)

The relationship of the neo-angiogenic marker, endoglin, with response to neoadjuvant chemotherapy in breast cancer
por: Beresford, M J, et al.
Publicado: (2006)

MicroRNA-345 induces apoptosis in pancreatic cancer cells through potentiation of caspase-dependent and -independent pathways
por: Srivastava, Sanjeev K, et al.
Publicado: (2015)

Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer
por: Voss, M A, et al.
Publicado: (2011)

Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma
por: Saroufim, A, et al.
Publicado: (2014)

Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma
por: Han, S, et al.
Publicado: (2014)

Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer
por: Mahon, K L, et al.
Publicado: (2014)

C4.4A as a candidate marker in the diagnosis of colorectal cancer
por: Paret, C, et al.
Publicado: (2007)

Prognostic value of increase in transcript levels of Tp73 ΔEx2-3 isoforms in low-grade glioma patients
por: Wager, M, et al.
Publicado: (2006)

NY-ESO-1 antibody as a novel tumour marker of gastric cancer
por: Fujiwara, S, et al.
Publicado: (2013)

Differential tissue-specific protein markers of vaginal carcinoma
por: Hellman, K, et al.
Publicado: (2009)

Downregulation of serum metabolite GTA-446 as a novel potential marker for early detection of colorectal cancer
por: Hata, Tsuyoshi, et al.
Publicado: (2017)

Expression of carbonic anhydrase 9, a potential intrinsic marker of hypoxia, is associated with poor prognosis in oesophageal squamous cell carcinoma
por: Tanaka, N, et al.
Publicado: (2008)

Reversibility of apoptosis in cancer cells
por: Tang, H L, et al.
Publicado: (2009)

Lack of correlation of stem cell markers in breast cancer stem cells
por: Liu, Y, et al.
Publicado: (2014)

Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia
por: Moniaux, N, et al.
Publicado: (2008)

RNA helicase DHX15 acts as a tumour suppressor in glioma
por: Ito, Shingo, et al.
Publicado: (2017)

Immunohistochemical markers of the hypoxic response can identify malignancy in phaeochromocytomas and paragangliomas and optimize the detection of tumours with VHL germline mutations
por: Pinato, D J, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gaq78u2sr7lv80dfulfoei9lgq